Skip to content

Medical Innovation Meets Regulatory Excellence

Getting Your Medical Device Licensed in Canada? Part 1: A Practical Guide to Health Canada’s Mandatory Regulatory Enrolment Process (REP)

July 5, 2026 – As of early 2026, REP is no longer optional. Health Canada will not accept PDF forms or email submissions for Class II, III, and IV medical device licence (MDL) applications. Every manufacturer or their regulatory correspondent must now submit electronically through structured XML templates via the Common Electronic Submissions Gateway (CESG).

FDA Cybersecurity Guidance for Medical Devices

March 15, 2024 – On March 13, 2024 the FDA released “Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the FD&C Act”, which includes clarification on several areas in the September 27, 2023 draft guidance document “Cybersecurity in Medical Devices: Quality System Consideration and Content of Premarket Submission.” In addition, recommendations for cybersecurity

2 Items